In line with our in vivo study, we assumed that Chr could also inhibit activated cells and intrapulmonary lethal cytokines and relieve ALI through the HMGB1/NF-κB pathway via the HDAC3 signaling. The gene discussed is NFKB1; the disease is acute respiratory distress syndrome.